Aclaris Therapeutics Stock Options
| ACRS Stock | USD 2.60 0.12 4.84% |
Aclaris Therapeutics' latest option contracts expiring on January 17th 2025 are carrying combined implied volatility of 2.1. The total put volume is at 11.0, with calls trading at the volume of 315. This yields a 0.03 put-to-call volume ratio. The Aclaris Therapeutics option chain provides detailed quote and price information for the current Aclaris Therapeutics option contracts. It shows all of Aclaris Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.
In The Money vs. Out of Money Option Contracts on Aclaris Therapeutics
Analyzing Aclaris Therapeutics' in-the-money options over time can help investors to take a profitable long position in Aclaris Therapeutics regardless of its overall volatility. This is especially true when Aclaris Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Aclaris Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Aclaris Therapeutics' stock while costing only a fraction of its price.
Aclaris Therapeutics In The Money Call Balance
When Aclaris Therapeutics' strike price is surpassing the current stock price, the option contract against Aclaris Therapeutics stock is said to be in the money. When it comes to buying Aclaris Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Aclaris Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Aclaris Current Options Market Mood
Aclaris Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Aclaris Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Aclaris Therapeutics' options investors are not very successful. Aclaris Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Aclaris contract
Base on the Rule 16, the options market is currently suggesting that Aclaris Therapeutics will have an average daily up or down price movement of about 0.13% per day over the life of the 2025-01-17 option contract. With Aclaris Therapeutics trading at USD 2.6, that is roughly USD 0.003413. If you think that the market is fully incorporating Aclaris Therapeutics' daily price movement you should consider buying Aclaris Therapeutics options at the current volatility level of 2.1%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Aclaris |
Purchasing Aclaris Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Aclaris calls. Remember, the seller must deliver Aclaris Therapeutics stock to the call owner when a call is exercised.
Aclaris Therapeutics Option Chain
When Aclaris Therapeutics' strike price is surpassing the current stock price, the option contract against Aclaris Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Aclaris Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Aclaris. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Aclaris. It also shows strike prices and maturity days for a Aclaris Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | ACRS250117C00001000 | 0 | 1.0 | 0.0 - 4.8 | 4.8 | In |
Call | ACRS250117C00002000 | 0 | 2.0 | 0.4 - 0.55 | 0.56 | In |
Call | ACRS250117C00003000 | 0 | 3.0 | 0.0 - 4.8 | 4.8 | |
Call | ACRS250117C00004000 | 0 | 4.0 | 0.0 - 4.8 | 4.8 | |
Call | ACRS250117C00005000 | 0 | 5.0 | 0.0 - 4.8 | 4.8 | |
Call | ACRS250117C00006000 | 0 | 6.0 | 0.05 - 0.85 | 0.73 | |
Call | ACRS250117C00007000 | 0 | 7.0 | 0.0 - 0.85 | 0.85 | |
Call | ACRS250117C00008000 | 0 | 8.0 | 0.0 - 1.3 | 1.3 | |
Call | ACRS250117C00009000 | 0 | 9.0 | 0.0 - 0.55 | 0.55 | |
Call | ACRS250117C00010000 | 0 | 10.0 | 0.0 - 0.45 | 0.14 | |
Put | ACRS250117P00001000 | 0 | 1.0 | 0.0 - 4.8 | 4.8 | |
Put | ACRS250117P00002000 | 0 | 2.0 | 0.0 - 2.5 | 2.5 | |
Put | ACRS250117P00003000 | 0 | 3.0 | 0.0 - 4.8 | 4.8 | In |
Put | ACRS250117P00004000 | 0 | 4.0 | 0.55 - 5.0 | 0.55 | In |
Put | ACRS250117P00005000 | 0 | 5.0 | 0.5 - 4.8 | 0.5 | In |
Put | ACRS250117P00006000 | 0 | 6.0 | 1.95 - 2.5 | 2.0 | In |
Put | ACRS250117P00007000 | 0 | 7.0 | 3.1 - 3.7 | 3.1 | In |
Put | ACRS250117P00008000 | 0 | 8.0 | 2.95 - 4.5 | 2.95 | In |
Put | ACRS250117P00009000 | 0 | 9.0 | 5.1 - 5.3 | 5.1 | In |
Put | ACRS250117P00010000 | 0 | 10.0 | 5.9 - 6.4 | 5.9 | In |
Aclaris Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Aclaris Total Stockholder Equity
Total Stockholder Equity |
|
Aclaris Therapeutics Corporate Executives
Elected by the shareholders, the Aclaris Therapeutics' board of directors comprises two types of representatives: Aclaris Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aclaris. The board's role is to monitor Aclaris Therapeutics' management team and ensure that shareholders' interests are well served. Aclaris Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aclaris Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Frank Ruffo | CFO CoFounder | Profile |
Additional Tools for Aclaris Stock Analysis
When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.